|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.030 USD | -3.74% |
|
-11.21% | -38.32% |
| 14/07 | Lineage Cell Therapeutics, Inc. - Special Call | |
| 13/07 | Lineage Cell Therapeutics Provides Update On COR1 Cell Therapy Program For Corneal Endothelial Disease | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.2 | 1.35 | 1.35 |
| Spread/Res. | -14.17% | -23.70% | -23.70% |
| Spread/Supp. | +1.98% | +19.99% | +7.19% |
| Support | 1.01 | 0.8584 | 0.9609 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
